Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term sodium valproate in pediatric spinal muscular atrophy
jRCT2080223395Phase 3Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of valproic acid in spinal muscular atrophy (SMA), sponsored by Kowa Company, Ltd. Started Nov 2016; status: completed.
02
Drugs
valproic acid
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on jRCT2080223395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223395.